Evidence map›Paper›PMID 30925830›Full record

ArticleMaterials (Basel, Switzerland)2019

Photocatalytic and Pozzolanic Properties of Nano-SiO₂/Al₂O₃-TiO₂ Powder for Functional Mortar.

Jong-Won Lee, Young-Il Jang, Wan-Shin Park, Sun-Woo Kim, Byung-Jae Lee

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Evaluation of Reducing NO and SOMaterials (Basel, Switzerland) · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jong-Won LeeDepartment of Convergence Systems Engineering, Chungnam National University, 99 Daehak-ro Yuseong-gu, Daejeon 34134, Korea. asca28@cnu.ac.kr.
Young-Il JangDepartment of Construction Engineering Education, Chungnam National University, 99 Daehak-ro Yuseong-gu, Daejeon 34134, Korea. jang1001@cnu.ac.kr.
Wan-Shin ParkDepartment of Construction Engineering Education, Chungnam National University, 99 Daehak-ro Yuseong-gu, Daejeon 34134, Korea. salshin@cnu.ac.kr.
Sun-Woo KimDepartment of Construction Engineering Education, Chungnam National University, 99 Daehak-ro Yuseong-gu, Daejeon 34134, Korea. sw.kim@cnu.ac.kr.
Byung-Jae LeeDepartment of Civil Engineering, Daejeon University, 62 Daehak-ro Dong-gu, Daejeon 34520, Korea. bjlee@dju.kr.

Funding

National Research Foundation of Korea 2015R1D1A1A01058109
6 · The paper itself

Abstract

The present study intended to find a way to use TiO₂, one of the most widely used photocatalysts, as a construction material. To that end, nano-SiO₂/Al₂O₃-TiO₂ powder (NTCP) was synthesized by coating SiO₂ and Al₂O₃ support materials with TiO₂. The NTCP was anatase phase spherical particles, specific surface areas were 319 m²/g and 267 m²/g for the SiO₂-TiO₂ powder and Al₂O₃-TiO₂ powder. UV absorption test results showed the developed NTCP had a light absorption peak at wavelengths of 380 nm or below, and its absorbance was much larger than that of commercial TiO₂. The NTCP formed smaller pores on the surface than commercial TiO₂. As a result, the flow of the mortar decreased as the adsorption strength increased and combined a large number of water molecules. In addition, the Pozzolanic reaction by SiO₂ and Al₂O₃ used as support materials produced many calcium silicate hydrate (C-S-H) and calcium aluminate hydrate (C-A-H). This has shown an increased strength of mortar mixed with the NTCP by promoting a nucleation effect and reducing the filling effect and the number of harmful holes in the mortar.

Indexed as

compress strengthconstruction materialmicro structuremortarnano-TiO2

Identifiers

PMID30925830
PMCPMC6480252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.